Valneva Stock in Oversold Territory: Support at €2.32 in Sight

A Worsening Decline Ahead of a Key Earnings Release

Valneva stock now shows a decline of 9.91% over the last seven days and 41.39% over three months, bringing its value to 20.71% below its level a year ago. This slide is a direct continuation of a movement that began in mid-April, when Goldman Sachs downgraded its recommendation on the stock, triggering a 7% drop on April 22. The financial calendar now provides an immediate benchmark: the company will publish its first-quarter 2026 revenue on May 7, which is about ten sessions away. The annual general meeting is then scheduled for June 1, 2026, followed by the semi-annual results on August 13. These events will be the next steps that could provide visibility on the operational trajectory of the laboratory, after a quarter marked by a sharp contraction in the stock price.

A Tense Technical Setup Below the Lower Bollinger Band

Technically, several signals converge towards a pronounced oversold configuration. The RSI stands at 25, which is in a characterized oversold zone (below the traditional threshold of 30), while the price is now below the lower Bollinger band set at €2.34. This exit from the bottom of the volatility channel constitutes a signal of extreme tension on the price dynamics. The support threshold at €2.32 appears as the critical technical level in the short term: crossing it would pave the way for new lows, while the stock trades at €2.3360 during the session. Conversely, the 50 and 200-day moving averages, at €3.73 and €3.89 respectively, remain well away from the current price, reflecting the depth of the decline initiated. The volatility over one month stands at 22.87, a level that highlights the amplitude of recent movements. The May 7 meeting, with the publication of the quarterly revenue, will be the next calendar catalyst identified for the stock.